Diabetes, Digestive, and Kidney Diseases Extramural Research in Colorado
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $235 million to recipients in Colorado in 237 grants from fiscal 2021 to 2025, 2.5% of the program's national total. The Regents of the University of Colorado received the most, $204 million.
- Awarded in Colorado$235 million
- Awards237
- Share of the program2.5%
- Rank among states17th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 128 | $43.9 million |
| FY 2022 | 125 | $48.6 million |
| FY 2023 | 122 | $48.0 million |
| FY 2024 | 115 | $46.1 million |
| FY 2025 | 101 | $48.2 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 183 | $204 million |
| Colorado State University | Colleges and universities | 8 | $9.8 million |
| The Regents of the University of Colorado | Colleges and universities | 9 | $5.5 million |
| Amidebio, LLC | Small businesses | 3 | $4.9 million |
| Aspero Medical, Inc. | Small businesses | 2 | $4.0 million |
| Cobio Diagnostics Inc. | Small businesses | 1 | $1.8 million |
| Denver Health and Hospital Authority | Other | 1 | $1.6 million |
| Trustees of the Colorado School of Mines | Colleges and universities | 2 | $841,924 |
| Gelsana Therapeutics Inc | Small businesses | 2 | $624,642 |
| University of Northern Colorado | Colleges and universities | 1 | $377,986 |
Open opportunities under this program
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
See all 68 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Colorado?
$235 million from fiscal 2021 to 2025, across 237 awards. Colorado ranks 17th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $204 million in 183 awards. Next are Colorado State University and The Regents of the University of Colorado.
Can organizations in Colorado apply now?
Yes, 68 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants